Wasawas, Maridel P.

HRN: 01-88-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2022
CLINDAMYCIN 300MG (CAP)
04/19/2022
04/21/2022
ORAL
300 Mg
Q8
None Healing Wound
Waiting Final Action 
04/08/2022
CEFTRIAXONE 1G (VIAL)
04/08/2022
04/14/2022
IV
2grams
OD
Sepsis 2° To Cutaneous Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: